Co-founder who has served in leadership positions at Johnson & Johnson, Boston Scientific and Medtronic and multiple start up medical technology companies. Recently President and COO for Medovex Corp (MDVX on the NASDAQ exchange). Patrick has also served as a member of the board of directors for several companies in the past and has been a featured presenter in the U.S. and the EU on topics of MedTech startup topics.
Highly qualified and accomplished in the startup space with a proven track record of success in the medical technology field. Patrick is the author of the book “The Inventors Guide for Medical Technology” and is a Fox Business News network contributor.
SubioMed is his eighth start up. He has successfully team raised funding in private and public markets.
Brian Bowen, C. Ped, MBA
Executive Vice President | Board Member | Co-Founder
Co-founder with leadership and consulting roles in consumer goods, pharmaceuticals, medical device, bracing, pedorthics, and foot + ankle implants and devices. Expertise in strategy, marketing management, R&D, sales management, and sales training.
His value creation experience ranges from large consumer brands to disruptive med device technology, including foot and ankle. Brian's approach to innovative technology seeks optimized value creation across all customer segments, including patients, providers, facilities, and payors.
Dr. Barry Butler, DPM
Founder | Chief Medical Officer
Board certified by the American Board of Podiatric Surgery (ABPS) and a Fellow of the American College of Foot and Ankle Surgeons (FACFAS).
As founder of Advanced Foot and Ankle Clinics LLP, Dr. Butler brings clinical insight from his 28 years of foot and ankle patient care. Dedicated to helping patients resume active, healthy lifestyles, his experience spans the foot and ankle spectrum and includes in-house fabrication of orthotics and bracing, non-surgical care, diabetic wound management, and complex surgical reconstruction.
His pioneering of Suspension Biomechanics, which includes multiple patents pertaining to motion control and energy return, is borne of medicine’s need to discover disruptive approaches in managing Ground Reaction Force (GRF), both for avoidance and management of pathology.